Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2

Clinical trial NCT04626089 · WITHDRAWN

Trial details

NCT number: NCT04626089
Sponsor: Laboratorios Silanes S.A. de C.V.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Severe Acute Respiratory Syndrome Coronavirus 2 Metabolic Syndrome Type 2 Diabetes

Start date: 2021-02-01
Primary completion: 2021-02-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.